Studies Presented at American Transplant Congress Support Clinical Utility of TGI’s TruGraf® Tests for Management of Kidney Transplant Recipients
Mansfield, MA, June 12, 2018 — Transplant Genomics Inc. (TGI), a [...]
Value of the TruGraf Blood Test as a Biomarker for Monitoring Renal Transplant Recipients
Insights in Biomedicine ISSN 2572-5610, April – 2018, vol.3 No.2:8 [...]
Clinical Utility Study Indicates Potential for TruGraf™ Test to Replace Surveillance Biopsies in Kidney Transplant Recipients with Stable Renal Function
Mansfield, MA, November 28, 2017 — Transplant Genomics Inc. (TGI), a molecular [...]
Clinical Utility of Peripheral Blood Gene Expression Profiling in Kidney Transplant Recipients to Assess the Need for Surveillance Biopsies in Subjects with Stable Renal Function
Journal of Transplant Technology & Research, November 2017, 7:3 Martin [...]
Study Shows TruGraf Blood Test Enables Non-invasive Detection of Immune Quiescent Kidney Transplant Recipients
Mansfield, MA, October 24, 2017 —Transplant Genomics Inc. (TGI), a molecular [...]
U.S. patent issues for gene expression profiles associated with chronic kidney allograft rejection, licensed exclusively to Transplant Genomics Inc.
Mansfield, MA, September, 2017 — The Scripps Research Institute (TSRI) has [...]
An Economic Analysis of the Cost Effectiveness of Blood Gene Expression Profiling in Kidney Transplant Recipients
Journal of Health & Medical Economics, July – 2017, ISSN [...]
Analytical and Clinical Validation of a Molecular Diagnostic Signature in Kidney Transplant Recipients
Journal of Transplantation Technologies & Research, September – 2017, 7:3 [...]
Genomic Signature for Predicting Acute Rejection in Liver Transplant Patients to be Presented at the American Transplant Congress
Chicago, IL, May 1, 2017— Dr. Josh Levitsky, Professor of Medicine [...]
Biomarker Guidelines for High-Dimensional Genomic Studies in Transplantation: Adding Method to the Madness
Transplantation March 2017 Volume 101 Number 3 Sunil M. Kurian, [...]